AU2098983A - Pharmaceutical 6alpha-methylcarticoids - Google Patents
Pharmaceutical 6alpha-methylcarticoidsInfo
- Publication number
- AU2098983A AU2098983A AU20989/83A AU2098983A AU2098983A AU 2098983 A AU2098983 A AU 2098983A AU 20989/83 A AU20989/83 A AU 20989/83A AU 2098983 A AU2098983 A AU 2098983A AU 2098983 A AU2098983 A AU 2098983A
- Authority
- AU
- Australia
- Prior art keywords
- methylcarticoids
- 6alpha
- pharmaceutical
- acyloxy
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 125000004423 acyloxy group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Detergent Compositions (AREA)
- Seasonings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Manufacture Of Tobacco Products (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823243482 DE3243482A1 (de) | 1982-11-22 | 1982-11-22 | Neue 6(alpha)-methylkortikoide, ihre herstellung und verwendung |
| DE32434820 | 1982-11-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2098983A true AU2098983A (en) | 1984-05-31 |
Family
ID=6178924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU20989/83A Abandoned AU2098983A (en) | 1982-11-22 | 1983-11-04 | Pharmaceutical 6alpha-methylcarticoids |
Country Status (22)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60161914A (ja) * | 1984-02-02 | 1985-08-23 | Green Cross Corp:The | ステロイド脂肪酸エステル含有直腸投与製剤 |
| JPS61274795A (ja) * | 1985-05-30 | 1986-12-04 | Toshiba Corp | 曝気槽の溶存酸素濃度制御装置 |
| US4968822A (en) * | 1987-12-11 | 1990-11-06 | Taisho Pharmaceutical Co., Ltd. | 21-alkoxysteroid compounds |
| JPH05501115A (ja) * | 1990-03-27 | 1993-03-04 | シェリング・コーポレーション | ９α―ヒドロキシ ステロイドの脱水法 |
| DE4333920A1 (de) * | 1993-10-05 | 1995-04-13 | Hoechst Ag | Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| ITMI20011762A1 (it) | 2001-08-10 | 2003-02-10 | Cosmo Spa | Esteri di 17alfa,21-diidrossipregnene, loro uso come agenti anti-androgenetici e procedimenti per la loro preparazione |
| ITMI20071616A1 (it) | 2007-08-03 | 2009-02-04 | Cosmo Spa | Processo enzimatico per l'ottenimento di 17-alfa monoesteri del cortexolone e/o suoi 9,11-deidroderivati. |
| JP5780521B2 (ja) * | 2008-05-28 | 2015-09-16 | リベラジェン・バイオファーマ・インコーポレイテッドＲｅｖｅｒａＧｅｎ ＢｉｏＰｈａｒｍａ，Ｉｎｃ． | 疾患を治療するための、ＮＦ−κＢの非ホルモン性ステロイド調節因子 |
| EP2556083A4 (en) | 2010-04-05 | 2013-12-04 | Validus Biopharma Inc | NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT |
| EP3108879A1 (en) | 2015-06-25 | 2016-12-28 | Cassiopea S.p.A. | High concentration formulation |
| WO2017004205A1 (en) | 2015-06-29 | 2017-01-05 | Reveragen Biopharma, Inc. | NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE |
| US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3053832A (en) * | 1957-04-29 | 1962-09-11 | Schering Corp | Alkylated cortical steroids |
| GB921533A (en) * | 1958-07-12 | 1963-03-20 | Syntex Sa | Cyclopentanophenanthrene derivatives and process for the production thereof |
| GB1047518A (en) * | 1963-06-11 | 1966-11-02 | Glaxo Lab Ltd | 17ª-monoesters of 11,17,21-trihydroxy steroid compounds |
| DE2645104C2 (de) * | 1976-10-04 | 1986-04-24 | Schering AG, 1000 Berlin und 4709 Bergkamen | 11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung |
| US4243586A (en) * | 1980-01-18 | 1981-01-06 | E. R. Squibb & Sons, Inc. | Steroidal-17-spiro-dihydrofuranones |
| US4336200A (en) * | 1980-01-31 | 1982-06-22 | The Upjohn Company | 17α-Acyloxy-5β-corticoids |
| US4318853A (en) * | 1980-01-31 | 1982-03-09 | The Upjohn Company | 9β,11β-Epoxy-5β-corticoids |
| ATE12237T1 (de) * | 1980-12-23 | 1985-04-15 | Schering Ag | Neue 6-alpha-methylhydrocortison-derivate, ihre herstellung und verwendung. |
-
1982
- 1982-11-22 DE DE19823243482 patent/DE3243482A1/de not_active Withdrawn
-
1983
- 1983-09-20 AT AT83109308T patent/ATE28651T1/de not_active IP Right Cessation
- 1983-09-20 DE DE8383109308T patent/DE3372776D1/de not_active Expired
- 1983-09-20 EP EP83109308A patent/EP0110041B1/de not_active Expired
- 1983-09-28 PT PT77408A patent/PT77408B/pt not_active IP Right Cessation
- 1983-10-13 ES ES526446A patent/ES8405421A1/es not_active Expired
- 1983-10-17 GB GB08327736A patent/GB2130587A/en not_active Withdrawn
- 1983-11-04 AU AU20989/83A patent/AU2098983A/en not_active Abandoned
- 1983-11-08 IL IL70160A patent/IL70160A/xx not_active IP Right Cessation
- 1983-11-18 DD DD83256872A patent/DD219200A5/de not_active IP Right Cessation
- 1983-11-21 PL PL1983250735A patent/PL141686B1/pl unknown
- 1983-11-21 PL PL25073483A patent/PL250734A1/xx unknown
- 1983-11-21 HU HU834000A patent/HU190746B/hu not_active IP Right Cessation
- 1983-11-21 RO RO83112614A patent/RO89343A/ro unknown
- 1983-11-21 CA CA000441605A patent/CA1303607C/en not_active Expired - Lifetime
- 1983-11-21 RO RO122112A patent/RO93593B/ro unknown
- 1983-11-21 PL PL1983244685A patent/PL138796B1/pl unknown
- 1983-11-21 NO NO834265A patent/NO157454C/no unknown
- 1983-11-21 GR GR73030A patent/GR79725B/el unknown
- 1983-11-21 IE IE2708/83A patent/IE56281B1/en not_active IP Right Cessation
- 1983-11-22 ZA ZA838720A patent/ZA838720B/xx unknown
- 1983-11-22 BG BG063156A patent/BG42677A3/xx unknown
- 1983-11-22 CS CS838675A patent/CS248712B2/cs unknown
- 1983-11-22 US US06/554,418 patent/US4645763A/en not_active Expired - Lifetime
- 1983-11-22 BG BG070923A patent/BG43867A3/xx unknown
- 1983-11-22 JP JP58218852A patent/JPS59106500A/ja active Granted
- 1983-11-22 DK DK533783A patent/DK159686C/da active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2098983A (en) | Pharmaceutical 6alpha-methylcarticoids | |
| AU560160B2 (en) | 6alpha-methylprednisolone derivatives | |
| AU548396B2 (en) | 2-aryl-3,4-diazabicyclo(4.n.0)alk-2-en-5-ones | |
| AU5670690A (en) | Lysolecithin derivatives for treating autoimmune diseases | |
| IL69230A (en) | 6,16-dimethyl corticoids,process for the preparation thereof and pharmaceutical compositions containing the same | |
| AU591075B2 (en) | Fatty acid diesters and cosmetic preparations therof | |
| AU546158B2 (en) | Cycloaliphatic pharmaceutical compounds | |
| AU1340888A (en) | 1,2-dehydrogenation of steroidal 21-esters with a. simplex | |
| AU578295B2 (en) | Phenyl-substituted naphthyridines and their use as anti-ulcer drugs | |
| AU553893B2 (en) | Imidazolidine derivatives | |
| IE833006L (en) | Substituted azabicycloalkanes. | |
| ZA903111B (en) | 2-hydroxy-3-phenoxypropylamino compounds and pharmaceutical compositions containing them | |
| AU584098B2 (en) | Substituted azabicycloheptanes, the use thereof, pharmaceutical preparations that contain these compounds, and processes for the manufacture of these compounds | |
| AU556675B2 (en) | 7alpha-acylthio-1alpha,2alpha-methylene-3-oxo-17alpha-preg- 4ene--21,17-carbolactones | |
| AU517601B2 (en) | Recovery of mg from sludge | |
| GR880300115T1 (en) | 1-methyl-15-alpha-alkyl-androsta-1,4-diene-3,17-diones, process for their preparation and pharmaceutical compositions containing them | |
| KR910000786A (ko) | 콜레스타디엔 유도체, 이의 제조방법 및 HMG-CoA 환원제를 저해하는 작용을 하는 약제로서의 이의 용도 |